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Summary 
Minor coat protein IIIa is conserved in all adenoviruses and required for correct viral assembly, 
but its precise function in capsid organization is unknown. The latest adenovirus capsid model 
proposes that IIIa is located underneath the vertex region. To obtain experimental evidence on 
the location of IIIa and further define its role, we engineered the IIIa gene to encode 
heterologous N-terminal peptide extensions. Recombinant adenovirus variants with IIIa encoding 
six-histidine tag (6-His), 6-His and FLAG peptides, or 6-His linked to FLAG with a (Gly4Ser)3 
linker were rescued and analyzed for virus yield, capsid incorporation of heterologous peptides, 
and capsid stability. Longer extensions could not be rescued. Western blot analysis confirmed 
that the modified IIIa proteins were expressed in infected cells and incorporated into virions. In 
the adenovirus encoding the 6-His-linker-FLAG-IIIa gene, the 6-His tag was present in light 
particles but not in mature virions. Immuno-electron microscopy of this virus showed that the 
FLAG epitope is not accessible to antibodies on the viral particles. Three-dimensional electron 
microscopy (3DEM) and difference mapping located the IIIa N-terminal extension beneath the 
vertex complex, wedged at the interface between penton base and the peripentonal hexons, 
therefore supporting the latest proposed model. The position of the IIIa N-terminus and its low 
tolerance for modification provide new clues for understanding the role of this minor coat protein 
in adenovirus capsid assembly and disassembly. 
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Introduction 
     Adenovirus (Ad) has been found in every class of vertebrates including mammals, birds, fish, 
amphibians and reptiles 1. In humans they cause common respiratory, gastrointestinal and eye 
infections, with 51 different serotypes described so far. Although the most common type of 
adenovirus infection is subclinical, adenovirus-induced diseases are responsible for significant 
morbidity in immuno-compromised patients and children in underdeveloped areas 2. They are 
widely used as vectors for gene therapy, and have showed promise in vaccine delivery and 
oncolysis 3; 4. Because of this dual relationship between adenoviruses and humans (as pathogenic 
agents and therapeutic tools), accurate knowledge of capsid structure is fundamental to both the 
discovery of anti-adenovirus drugs and the design of new, efficient viral vectors for gene 
therapy. 
     At least 11 structural proteins combine to form the non-enveloped icosahedral adenovirus 
capsid that contains the dsDNA-protein core complex. The virion has a diameter of 
approximately 900 Å not counting the fibers, and a particle mass of 150x106 Da 5. Each capsid 
facet has 12 trimers of the major coat protein, hexon. At each vertex, five penton base subunits 
form the penton base, which is complexed with a trimer of the long projecting fiber. The crystal 
structures of hexon and the vertex proteins (penton base and fiber) have been solved 6; 7; 8; 9. 
     Atomic resolution structures are not presently available for any of the adenovirus minor coat 
proteins (polypeptides IIIa, VI, VIII and IX). These proteins are thought to play a dual role in 
stabilizing the virion while allowing the flexibility necessary for its disassembly during infection 
10
. However, the specific role of each minor coat protein in capsid assembly is not known. 
     Polypeptide IIIa is conserved in all adenoviruses described so far 1, with an estimated copy 
number of 60 5; 11; 12. In human adenovirus type 5 (Ad5) the 585 amino acid precursor pIIIa is 
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cleaved by the viral protease during particle maturation, removing 15 residues from its C-
terminus and giving rise to the 570 amino acid, 63.5 kDa mature protein 12; 13. Polypeptide IIIa 
has a role in capsid assembly, as shown by studies on the Ad2 ts112 mutant. When grown at the 
non-permissive temperature, ts112 contains similar amounts of IIIa as the wild type virus, but it 
produces mainly low density particles depleted in core components 14. These are reminiscent of 
assembly intermediates blocked at a late stage of assembly, probably DNA encapsidation.  
     Early experimental work produced somewhat conflicting evidence about the location of IIIa. 
On one hand, co-immunoprecipitation and cross-linking assays indicated that IIIa was interacting 
with core polypeptide VII, and was thus probably internally placed 12; 15. On the other hand, a 
serum raised against IIIa was able to immunoprecipitate intact virions 15, suggesting exposure on 
the outer capsid surface. Assays estimating the degradation rates of proteins in the virion by 
Argon plasma etching found that IIIa and polypeptide VI are degraded at intermediate rates, 
suggesting a position inside the capsid but not deep in the core 16. A model based on combined 
electron microscopy (EM)/X-ray imaging studies on Ad2 11 fulfilled both requirements by 
placing IIIa at the facet edges, with about 2/3 of the protein bulk on the external capsid surface, 
while the rest was assigned to an inner density region directly below. However, recent studies 
have challenged this and other assignments of minor coat protein localizations in the capsid. 
     First, reconstructions of polypeptide IX-deleted mutants showed that the lack of IX resulted in 
loss of density at both the positions assigned to IX and the external part of IIIa 17; 18. While Fabry 
and coworkers interpreted their maps in terms of IIIa being present only outside the capsid and 
destabilized in the absence of IX, Scheres and coworkers showed immunolabeling data 
suggesting that IIIa is not exposed at the virion surface. Second, a 3DEM map of adenovirus with 
GFP fused to the C-terminus of IX showed extra density above the external position assigned to 
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IIIa, raising the possibility that either the density on the capsid surface assigned to IIIa 
corresponds to the C-terminal region of IX instead, or that modifications to IX result in the 
ejection of IIIa 19. Third, a 6 Å resolution adenovirus map interpreted with the help of secondary 
structure predictions has proposed new locations for all minor coat proteins, reassigning IIIa to 
an internal position close to the vertex 20. Whereas all these interpretations are plausible and 
consistent with their respective data, the need for direct experimental evidence for minor capsid 
protein locations is clear. A recent study on the structure of canine adenovirus supports the 
location of the C-terminal domain of IX at the capsid edges 21, but there is at present no 
experimental confirmation regarding the position of IIIa or any of the other minor coat proteins. 
    Here we describe the design, construction and characterization of Ad5 mutants containing 
heterologous peptide extensions at the N-terminus of protein IIIa. The behavior of the different 
constructs regarding viral rescue, extension incorporation and capsid stability is evaluated. 
3DEM analyses reveal the location of the IIIa N-terminal extension within the capsid. The 
implications of our findings for the role of polypeptide IIIa in viral assembly and disassembly are 
discussed. 
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Results 
     To investigate the role of polypeptide IIIa in adenovirus capsid assembly, we constructed 
recombinant Ad genomes encoding heterologous peptide extensions at the N-terminus of IIIa 
(Fig. 1).  The N-terminus was selected because the pIIIa C–terminus is cleaved off by the 
adenoviral protease during virion maturation 13. Peptide extensions were incorporated into IIIa 
between the first two methionines and included a 6-His tag (Ad5H6IIIa), an 18-residue extension 
comprised of a 6-His tag and a flexible FLAG-containing linker (Ad5Luc1-HFpIIIa), and a 31-
residue extension containing a 6-His tag, a flexible linker containing three G4S repeats and a 
FLAG peptide (Ad5GLflagIIIa).  To explore the capacity of the IIIa capsid locale to tolerate 
more structurally complex moieties, we introduced a 60-residue extension containing a 37-
residue (45Å) alpha helix spacer 22 between the 6-His and FLAG sequences (Ad5Luc1-
H45FpIIIa). We have previously incorporated fluorescent proteins to other capsid components 
thereby allowing direct imaging of vector particles 23; 24. To explore the compatibility and 
function of this moiety at the IIIa locale, we inserted the eGFP open reading frame between the 
FLAG and 6-His tags (Ad5Luc1-HeGFPFpIIIa). 
     Following construction and verification of recombinant Ad genomes containing modified IIIa, 
PacI-linearized genomes were transfected into 293 cells for virus rescue. Three of the genomes, 
Ad5H6IIIa, Ad5Luc1-HFpIIIa, and Ad5GLflagIIIa produced viral propagation and cytopathic 
effect (CPE). However, introduction of Ad5Luc1-H45FpIIIa and Ad5Luc1-HeGFPFpIIIa 
genomes into 293 cells did not result in CPE after multiple attempts. On this basis, we concluded 
that these IIIa species were not compatible with the formation of new viral particles and 
represented a block to Ad propagation. 
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The rescued Ad5H6IIIa, Ad5Luc1-HFpIIIa, and Ad5GLflagIIIa constructs were propagated 
in 293 cells and analyzed for capsid incorporation of heterologous peptide sequences. The 
expression of modified IIIa genes in the context of Ad5H6IIIa, Ad5Luc1-HFpIIIa, and 
Ad5GLflagIIIa genomes was validated by Western blot using monoclonal antibodies (mAb) 
specific for 6-His or FLAG peptides. As shown in Fig. 2A, multiple polypeptides containing 6-
His or FLAG tag were observed in the lysates of 293 cells infected with Ad5H6IIIa, Ad5Luc1-
HFpIIIa, or Ad5GLflagIIIa virus but not with control Ad5GL vector. The detection of major 
protein bands with molecular mass of 65 kDa, as expected for the modified polypeptides IIIa, 
confirmed the synthesis of full-size protein IIIa containing the N-terminal FLAG and/or 6-His 
tags upon Ad infection. To study incorporation of modified IIIa proteins into the capsid, 
Ad5H6IIIa, Ad5Luc1-HFpIIIa, and Ad5GLflagIIIa viruses were purified on CsCl gradients. Both 
the upper viral band containing defective viral particles and the lower band representing mature 
virions separated during the first centrifugation were collected and purified on a second CsCl 
gradient. We have not observed significant differences between virus preparations in amount of 
defective particles relative to mature virions. The total yields of mature virions purified from 
equal number of cells infected with Ad5H6IIIa, Ad5Luc1-HFpIIIa, Ad5GLflagIIIa, and Ad5GL 
were estimated as 3.4 × 1012, 1.7 × 1012, 3.9 × 1012, and 5.8 × 1012 viral particles, respectively. 
The capsid incorporation of modified IIIa polypeptides was assessed in the context of defective 
and normal virions using Western blot analysis for the presence of IIIa-incorporated 6-His and 
FLAG peptides as described above. As can be seen in Fig. 2B, the 6-His tag was present in 
Ad5H6IIIa defective particles, while both the 6-His and FLAG tags were detected in immature 
Ad5Luc1-HFpIIIa and Ad5GLflagIIIa virions as was expected from the IIIa gene modifications 
introduced into the corresponding viral genomes. When mature virions were analyzed, positive 
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signals were detected for both Ad5Luc1-HFpIIIa and Ad5GLflagIIIa when probed with an anti-
FLAG mAb, as well as for Ad5H6IIIa and Ad5Luc1-HFpIIIa with an anti-Penta-His mAb. 
However, no 6-His-containing protein was detected in mature Ad5GLflagIIIa virions. While 
confirming the presence of intact 6-aa and 18-aa peptide extensions at the IIIa N-terminus in 
mature Ad5H6IIIa and Ad5Luc1-HFpIIIa viral particles, these data indicated that a part of the 
31-aa extension that includes the 6-His tag is absent from Ad5GLflagIIIa particles, even if the 
complete extension is correctly expressed and incorporated into immature particles. 
      Since previous evidence indicated a role for polypeptide IIIa in capsid assembly, we tested 
the thermostability of Ad5Luc1-HFpIIIa and Ad5GLflagIIIa virions to see whether extensions of 
the IIIa N terminus affected the efficiency of virus infection. The relative stability of Ad5Luc1-
HFpIIIa, Ad5GLflagIIIa, and Ad5GL was assessed based on reduction of Ad-mediated gene 
transfer levels subsequent to virus incubation at 45°C which were calculated with respect to 
untreated virus samples. These experiments did not reveal any significant changes in infectivity 
of Ad5Luc1-HFpIIIa and Ad5GLflagIIIa viruses as compared to the Ad5GL control (Fig. 3) 
thereby indicating that the N-terminal extensions introduced into protein IIIa do not interfere 
with viral capsid integrity required for cell infection. 
     We then used Ad5GLflagIIIa for studies aimed to elucidate the location of the N-terminal IIIa 
modification in the capsid. We first performed immuno-electron microscopy (immuno-EM) 
using a gold-conjugated secondary Ab for visual detection of the N-terminal tag. As positive 
controls, we included Ad5EZ-pIX-Flag-45A-6His F5/3 and Ad5EZ-pIX-Flag-10A-6His F3/3 
vectors that encode modified IX proteins displaying both FLAG and 6-His sequences separated 
by either 45Å or 10Å alpha helix spacers, respectively. No significant label was detected on 
Ad5GLflagIIIa viral particles, neither intact nor broken, in experiments performed with either 
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anti-6-His–tag or anti-FLAG antibodies. Both antibodies successfully recognized the 
corresponding epitopes when displayed at the polypeptide IX C-terminus (Fig. 4), even showing 
quantitative label differences related to the different accessibility of the 6-His tag when two 
constructions with different linker lengths were compared (Table 1). This indicates that the 
FLAG epitope in the IIIa extension, while present in the capsid as shown by Western blot, is 
masked by other viral components. 
     To localize the N-terminus of polypeptide IIIa in the capsid, we calculated a difference map 
between three-dimensional cryoEM reconstructions of the modified Ad5GLflagIIIa and of the 
original Ad5GL vector encoding native IIIa. Special care was taken to use similar imaging 
conditions for both datasets, thereby minimizing differences caused by the effect of the 
microscope contrast transfer function. Both maps were calculated using a similar number of 
images and the same image processing procedures, and filtered at the same final resolution (14 
Å). Since the only difference between both specimens is the N-terminal extension in IIIa, 
positive difference peaks in an Ad5GLflagIIIa-Ad5GL difference map should reveal the position 
of the extra residues, and therefore of polypeptide IIIa N-terminus. Fig. 5a shows a central cross 
section of the Ad5GL and Ad5GLflagIIIa maps, and of the difference between them. The 
strongest positive difference peaks (over 3σ above noise level) appear inside the protein shell, 
close to the vertices. Vertex density was weaker than that of hexons in the Ad5GLflagIIIa map, 
which originated a negative difference peak encompassing the penton. The Ad5GLflagIIIa 
penton occupancy was only 45% that of the control Ad5GL. This indicates that on average, more 
than 6 pentons are lost per particle. It was therefore necessary to investigate the possibility that 
the positive difference peaks close to the penton arose as a consequence of structural 
rearrangements due to the absence of some vertex components. 
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     Since it is not possible to differentiate particles lacking part of their pentons directly in the 
experimental images, we resorted to a single particle reconstruction (SPR)-based classification 
method 18. SPRs were obtained for all particles in the Ad5GLflagIIIa dataset, using an algorithm 
previously shown to reduce the SPR artifacts at the symmetry axes. Two subsets containing 
approximately 30% of the complete original image dataset each were selected, and used to 
calculate two 3D maps corresponding to those particles with highest (Ad5GLflagIIIa_high) and 
lowest (Ad5GLflagIIIa_low) penton densities. These maps were subsequently compared to a 
map calculated from a similar number of Ad5GL particles selected at random throughout the 
defocus groups (Ad5GL_subset). Penton occupancy was 71% and 7% for the 
Ad5GLflagIIIa_high and Ad5GLflagIIIa_low maps, respectively. Difference maps calculated 
between either Ad5GLflagIIIa_high or Ad5GLflagIIIa_low, and the Ad5GL_subset map, at 18 Å 
resolution, are shown in Fig. 5c. The (Ad5GLflagIIIa_high minus Ad5GL_subset) map was 
noisier than the others, but it showed the same positive difference located adjacent to the 
innermost region of penton. A difference map between Ad5GLflagIIIa_high and 
Ad5GLflagIIIa_low showed no significant difference at this position (not shown). Therefore we 
conclude that the positive difference peak is not related to penton loss but to the presence of the 
IIIa N-terminal extension. The (Ad5GLflagIIIa_low minus Ad5GL_subset) map did not show 
any significant negative difference peaks other than the penton itself, indicating that even in the 
lowest penton occupancy particles no other icosahedrally ordered components were lost. 
     A surface rendering of the 14 Å resolution difference map contoured at 3σ sigma level over 
the Ad5GL 3D map is shown in Fig. 6a, c. There were no significant difference peaks outside 
the capsid. The strongest peaks above noise level are located on the inner shell surface, close to 
the interface between penton base and the peripentonal hexons. There are 60 such peaks in the 
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difference map, in agreement with the biochemically determined polypeptide IIIa copy number 
11; 12
. The difference peak is nestled within a canyon (Fig. 6c), and is seen to be masked by other 
densities when the contouring threshold of the Ad5GL map is slightly lowered (not shown). This 
may explain why there was no label in broken particles in our immuno-EM studies. Fitting of a 
FLAG peptide crystallographic model into one of the difference peaks shows that its volume is 
just large enough to contain the FLAG tag (Fig. 6b). Fitting of the high resolution structures of 
penton base 7 and hexon 6 onto the Ad5GL map provides a clearer view of the position of the IIIa 
N-terminus with respect to these capsid components (Fig. 6d, e). The IIIa N-terminal extension 
is located at the opening of a crevice defined by the penton base and two adjacent peripentonal 
hexons. The center of the difference peak is approximately 15 Å away from the closest atoms 
present in the penton base and hexon structures. Five residues in each terminus of hexon, and 51 
residues at the penton base N-terminus, are not present in their crystal structures, but are in 
regions oriented towards the core. The N-terminus of polypeptide IIIa, as located by our 
difference mapping, is within reach of interactions with some of these terminal residues. 
  
12 
Discussion 
     We have tested the effect of modifying adenovirus minor coat protein IIIa on capsid assembly 
and stability. The N-terminus of IIIa was chosen for incorporating extensions, due to proteolysis 
of the C-terminus during virus maturation. We have determined the position of the N-terminus of 
adenovirus minor coat protein IIIa by peptide-based difference mapping of cryoEM 3D 
reconstructions. The power of this technique was first demonstrated when the N-terminus of 
hepatitis B virus capsid protein was localized by addition of eight extraneous residues, which 
were visible in the difference map even at moderate (20 Å) resolution 25. Our results emphasize 
once more the potential of this methodology, by locating a similarly small extension in the much 
larger adenovirus capsid (~950 vs. ~300Å diameter, 20 times larger in mass). 
     The Ad5GLflagIIIa recombinant virus encodes a 31-residue extension at the N-terminus of 
IIIa. Western blot analyses showed that the entire 31 residue-modified IIIa protein was expressed 
in infected 293 cells and incorporated into low density Ad5GLflagIIIa particles representing 
defective virions. However, the IIIa protein contained in mature virions does not contain the N-
terminal 6-His tag. The most likely explanation of this finding is that the 6-His tag is cleaved by 
the adenoviral protease 13 during Ad5GLflagIIIa particle maturation, since (M/I/L)XGX-G and 
(M/I/L)XGG-X consensus sites26 are present in the flexible linker between 6-His and FLAG 
sequences in the engineered N-terminal IIIa extension. 
     The only part of the 31-residue extension that was unequivocally present in Ad5GLflagIIIa 
virions was the FLAG peptide. Since there are no detectable epitopes in the flexible linker, it is 
not possible to determine the exact extension length(s) of IIIa in these virions. The difference 
peak corresponding to the IIIa N-terminal extension in the 3DEM difference map is just large 
enough to accommodate a structured FLAG peptide. This would agree with either the FLAG tag 
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being the only part of the extension present in most of the viral particles, or with the FLAG being 
the only extension element ordered enough to appear in an averaged, icosahedrally symmetric 
3D map. This would be expected, as the FLAG tag is the region of the heterologous peptide 
closest to the protein native N-terminus. 
     The positions of adenovirus minor coat proteins in the capsid were established in one of the 
first combined X-ray/3DEM imaging studies 11. Recently, a new model has been proposed based 
on an improved  3DEM map (6 Å vs. 25 Å resolution) and secondary structure predictions 20. 
Experimental confirmation on the location of as many capsid components as possible will 
facilitate interpretation of any future adenovirus structural data. Our difference map places the 
IIIa N-terminal extension close to the newly predicted position for IIIa, at the inner interface 
between penton base and the peripentonal hexons, and therefore supports the new model. 
Previous evidence indicated that at least part of IIIa would be exposed on the capsid surface 15. 
Both the model by Saban et al. 20 and the results reported here refer only to the position of the N-
terminal region of polypeptide IIIa, so there might still be a question of whether the C-terminal 
region of IIIa is actually exposed. Several lines of evidence support the hypothesis that it would 
also be internally located, possibly in contact with the viral core. First, 15 residues at the C-
terminus of pIIIa are cleaved by the adenoviral protease upon virion maturation 13. The protease 
is packaged together with the viral genome and uses DNA as a cofactor 27, so presumably the 
cleavage region has to be close to the core. Second, previous immunoEM assays using a 
polyclonal serum against IIIa showed labeling of broken particles only 18. This indicates that not 
only the N-terminal region, but epitopes throughout the polypeptide chain are not accessible to 
antibodies from the outside. 
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     Our results show that there is little tolerance for incorporation of extensions at the N-terminus 
of IIIa, such that only the shortest and less structured ones could be rescued. This implies a 
relevant role for this region of the protein during assembly. Although heat treatment assays 
indicated no detectable difference in infectivity between viruses containing wildtype or modified 
IIIa, it is interesting that the penton density in our Ad5GLflagIIIa 3DEM map is weaker than that 
of hexons, indicating that in these viruses there is a tendency to release vertex proteins. This is 
not an uncommon occurrence in adenovirus preparations, depending on the particular 
purification protocol or storage conditions 17; 19, and so it must be interpreted with caution. 
However, it is tempting to relate partial penton loss with the modifications introduced in the IIIa 
N-terminus, which we have mapped to the interface between penton base and the peripentonal 
hexons on the inner capsid surface. 
     It has been reported that the Ad2 ts112 mutant, with just three amino acid changes in 
polypeptide IIIa, accumulates light particles with little or no DNA when produced at the non-
permissive temperature 14; 28. This is a sign that IIIa has a role in correct genome packaging. Like 
Ad5GLflagIIIa, Ad2 ts112 has a tendency to lose pentons, as shown by gaps in the capsid in 
negatively stained EM images 14. Structural studies have revealed a striking similarity between 
adenovirus and the bacterial virus PRD1 29; 30; 31. In the PRD1 crystal structure, the position 
under the vertex at which we find the IIIa N-terminus is occupied by the small (117 residues) 
capsid protein P16 32. P16 links the icosahedral PRD1 capsid to its internal membrane, a 
structural feature that does not exist in adenovirus. Nevertheless, like we show here for the IIIa 
N-terminus, five copies of P16 are present at each vertex. They interact with the PRD1 penton 
base P31, the peripentonal P3 capsomers, and the small cementing protein beneath the capsid 
edges P30. PRD1 mutants lacking P16 can assemble and package the viral genome with as much 
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efficiency as the wild type virus, but upon purification they lose the DNA and the vertex 
structures, much as seen for the Ad2 ts112 mutant 33. It seems therefore likely that IIIa is the 
adenovirus counterpart of PRD1 P16. Both proteins would be required for stabilization of the 
vertex and the packaged genome, and may be involved in coordination of DNA release events 
during infection. 
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Materials and Methods  
Construction of recombinant IIIa-modified Ad genomes. To achieve the genetic 
modifications of the N-terminus of IIIa we cloned a PmlI-HincII DNA fragment (2820 bp) 
including the IIIa open reading frame (ORF) from plasmid pTG3602 34 containing the Ad5 
genome between SmaI and HincII sites in pBluescriptIISK plasmid (Stratagene, La Jolla, CA) 
generating plasmid pBsIIIa. To introduce a unique restriction site into the 5’-end of the IIIa gene, 
PCR primers pIIIaN6His.U (5’-cac cat cac cat cac cat ATG CAA GAC GCA AC) and 
pIIIaN6His.L   (5’-atg gtg atg gtg atg gtg CAT CTG ATC AGA AAC ATC) were designed to 
encode six consecutive histidines (6-His tag, low case letters) followed by a NdeI recognition site 
(underlined). The pBsIIIa plasmid DNA was used as a template to amplify two DNA fragments, 
740-bp and 261-bp long, using the following pairs of primers: pIIIaN.F (5’-CGC GAG GAG 
GTG GCT ATA GAC TGA) and pIIIaN6His.L, pIIIaN6His.U and pIIIaN.R (5’-TTC GGC CAG 
CGC GTT TAC GAT C), respectively. DNA fragments were purified and then joined by a 
second PCR using pIIIaN.F and pIIIaN.R primers. The resultant PCR fragment (983 bp) was 
digested with BsmI and MluI and the 738-bp DNA fragment was ligated with the BsmI-MluI 
fragment of pBsIIIa plasmid generating plasmid pBs6HIIIa. This plasmid encodes IIIa with both 
a 6-His tag and NdeI site between the first two methionine residues, and formed the basis of all 
subsequent IIIa modifications. 
     To incorporate a FLAG octapeptide (Asp-Tyr-Lys-Asp-Asp-Asp-Asp-Lys) downstream of 
the 6-His tag in the N-terminus of IIIa, 5’-phosphorylated oligonucleotides AgeIFLAG-F (5’-T 
ACC GGT GAT TAT AAG GAT GAC GAT GAC AAG AGC GC) and AgeIFLAG-R (5’-T 
AGC GCT CTT GTC ATC GTC ATC CTT ATA ATC ACC GG) were annealed to form a 
DNA duplex encoding a FLAG peptide with an AgeI site upstream of the FLAG (in bold) and an 
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AfeI site downstream (underlined). This oligo contains NdeI-compatible 5’-cohesive ends, and 
was ligated with NdeI-digested pBs6HIIIa to generate shuttle plasmid pBs6HisAgeIFLAGpIIIa, 
which encodes an 18aa N-terminal IIIa extension.  To insert a 45 Å helical spacer 22 between the 
6-His tag and FLAG sequence, plasmid pBs6HisAgeIFLAGpIIIa was digested with AgeI, cutting 
the plasmid between the 6-His and FLAG sequences. The 45 Å linker was PCR amplified with a 
forward primer containing an AgeI restriction site (in bold) (5’-
AGCTAACCGGTGAGACGCGG) and a reverse primer containing an XmaI site (in bold) (5’-
GCTCAGCCCGGGTGGGATCT). A cDNA clone of APOE4 vector from human skin 
(GenBank I.D.: BC072022, BU839307; I.M.A.G.E. Clone ID:6263100) in pOTB7 vector  from 
ATCC (#8291716) was used as a PCR template to amplify the 45 Å spacer sequence. The spacer 
PCR product was then digested with AgeI/XmaI to create AgeI cohesive ends, and ligated into 
AgeI-digested pBs6HisAgeIFLAGpIIIa, resulting in shuttle plasmid 
pBs6HisAgeIFLAGpIIIa45A, which encodes a 60aa extension. To incorporate eGFP into the IIIa 
N-terminus, the eGFP ORF was PCR-amplified with forward primer containing and AgeI site (in 
bold) (5’-CTAGTACCGGTATGGTGAGCAAGG) and a reverse primer containing an XmaI 
site (in bold) (5’-CTGGACCCGGGCTTGTACAGCTCGT), digested with AgeI/XmaI to create 
AgeI cohesive ends, and ligated into AgeI-digested pBs6HisAgeIFLAGpIIIa to create shuttle 
plasmid pBs6HisAgeIFLAGpIIIaeGFP, which encodes a 256aa extension. To incorporate a 
flexible linker and FLAG octapeptide downstream of the 6-His tag in the N-terminus of IIIa, 
oligonucleotides 5’- TAT TGG TGG AGG CGG TTC AGG CGG AGG TGG CTC TGG CGG 
TGG CGG ATC CGA TTA TAA GGA TGA CGA TGA CAA GGA and 5’- TAT CCT TGT 
CAT CGT CAT CCT TAT AAT CGG ATC CGC CAC CGC CAG AGC CAC CTC CGC CTG 
AAC CGC CTC CAC CAA were synthesized. The oligos were annealed to form a DNA duplex 
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encoding the (Gly4-Ser)3 flexible linker followed by the FLAG peptide while containing the 
NdeI-compatible 5’-cohesive ends and ligated with NdeI-digested pBs6HIIIa to generate plasmid 
pBs6HllFlagIIIa. 
     To generate genomic plasmids, the BsmI-HincII DNA fragment isolated from pBs6HIIIa 
(2675 bp) or pBs6HllFlagIIIa (2750 bp) was used for homologous DNA recombination with Ad5 
genome plasmids pTG3602 34 or pAd5GL 35 linearized with PmeI within the IIIa ORF, 
respectively. For IIIa N-terminal modifications of 18aa (6-His and FLAG), 60 (containing also a 
helical linker) and 256 (encoding eGFP), shuttle vectors pBs6HisAgeIFLAGpIIIa, 
pBs6HisAgeIFLAGpIIIa45A and pBs6HisAgeIFLAGpIIIaeGFP were digested with 
EcoR1/XhoI/XmnI, and the EcoR1/XhoI fragments containing the modified IIIa ORF were 
isolated.  These fragments were then used for homologous recombination with PmeI-linearized 
genome plasmid pAdEasy1CMVLuc-∆pIIIa.  This is a pAdEasy1-based Ad5 genome that 
encodes a CMV promoter/firefly luciferase expression cassette in the E1, but contains a deletion 
of the N-terminal region of IIIa, encoding the C-terminal 833 bp of the IIIa ORF as well as the 
native PmeI site in the IIIa region.  
     The resultant pAd5H6IIIa, pAd5GLflagIIIa, pAd5Luc1-HFpIIIa, pAd5Luc1-H45FpIIIa 
pAd5Luc1-HeGFPFpIIIa genomic plasmids were digested with PacI to release viral genomic 
DNA and transfected into 293 cells as described elsewhere 36; 37 to rescue the replication 
competent Ad5H6IIIa and all other replication-deficient constructs. All IIIa-modified viruses and 
the previously described Ad5GL 35 control vector were propagated on 293 cells, purified by 
centrifugation on CsCl gradients, and dialyzed against PBS (8 mM Na2HPO4, 2 mM KH2PO4, 
137 mM NaCl, and 2.7 mM KCl [pH 7.4]) containing 10% glycerol. The titer of physical viral 
particles (v.p.) was determined by the methods of Maizel et al. 38. 
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Construction of recombinant IX-modified Ad. Ad vectors Ad5EZ-pIX-Flag-10A-6His F3/3 
and Ad5EZ-pIX-Flag-45A-6His F5/3 were constructed based on the Ad5 AdEasy backbone with 
deleted E1 and E3 regions. Both viruses were replication defective and had a cytomegalovirus 
(CMV) promoter-driven firefly luciferase reporter gene (luc) cassette placed in the E1 region.  
Each virus carried an 8 aa FLAG sequence at the C-terminus of polypeptide IX fused to a 
GSRGS(H)6 sequence motif via a spacer. While Ad5EZ-pIX-Flag-10A-6His F3/3 virus had a 10 
aa spacer sequence P(SA)4P between the FLAG and the GSRGS(H)6  motif,  Ad5EZ-pIX-Flag-
45A-6His F5/3 virus  carried a 37-aa long spacer (EETRARLSKELQAAQARLGAD 
MEDVCGRLVQYRGEVH) with an α-helical structure also known as the “45Å spacer” 22. Each 
spacer was connected to the polypeptide IX-FLAG via a two-amino acid LA linker encoded by 
the sequence of the NheI site, 3’- adjacent to the FLAG sequence. The viruses also possessed 
modified fiber protein chimeras with the Ad3 serotype fiber knob domains and either Ad5 
(Ad5EZ-pIX-Flag-45A-6His F5/3) or Ad3 (Ad5EZ-pIX-Flag-10A-6His F3/3) serotype fiber 
shaft domains. 
     A conventional PCR-based approach followed by cloning of the PCR products into the NheI 
site of the shuttle plasmid pShlpIX Flag was used to generate its derivatives carrying the IX-
FLAG sequence fused to the 6-His containing motif via two different spacers. To amplify the 10 
aa spacer with the GSRGS(H)6  motif a shuttle plasmid pNEB.pk.RGS6HSL containing Ad5 
fiber gene with GSRGS(H)6  at the C-terminus was used as a PCR template 39 and the following 
sense and anti sense PCR primers, respectively: 5’-TGA CAA GCT AGC CCC ATC AGC CTC 
CGC ATC T; 5’-GCG TTA GCT AGC TTA GGA TCG GGT TTA TTA G. The following sense 
and anti-sense PCR primers were used to amplify the 45Å-spacer sequence with GSRGS(H)6: 5’-
TGA CAA GCT AGC CGA GGA GAC GCG GGC ACG GCT GTC CAA GGA G; 5’-ATG 
  
20 
GTG ATG CGA TCC TCT CGA TCC ATG CAC CTC GCC GCG GTA C. Another anti-sense 
primer 5’-TTT AAA GCT AGC TTA TTA GTG ATG GTG ATG GTG ATG CGA TCC TCT 
CGA TCC was used in the second step PCR with the same sense primer to extend the product of 
the first step reaction and add the sequence corresponding to the GSRGS(H)6. NheI site 
recognition sequences are underlined. A cDNA clone of APOE4 vector from human skin 
(GenBank I.D.: BC072022, BU839307; I.M.A.G.E. Clone ID:6263100) in pOTB7 vector  from 
ATCC (#8291716) was used as a PCR template to amplify the 45 Å spacer sequence. 
     To introduce the above protein IX modifications into the AdEasy-1 backbone, carrying either 
F5/3 or F3/3 fiber genes, the corresponding pShuttle plasmids were linearized with PmeI 
(between the homology arm sequences) and recombined with AdEasy-1F5/3 or AdEasy-1F3/3 
backbone plasmids in BJ5183 strain of E. coli as described previously 40.  In order to generate 
AdEasy-1 backbones with F5/3 or F3/3 fibers we first generated AdEasy-1 with fiber gene 
replaced by a unique SwaI site and then recombined the SwaI-linearized fiberless backbone with 
two shuttle vectors pKAN3.1F5/3 and pKAN3.1F3/3 as described elsewhere 41. The fiberless 
AdEasy-1 was constructed by recombination of the commercial AdEasy-1 vector with 
pZero2∆E3.6.9, which in turn was derived from the parental pZero2E3.6.9 plasmid by deletion 
of the E3 region by a two step PCR approach. Briefly, in the first step two pairs of PCR primers 
were used to generate a couple of PCR fragments, amplifying 160 and 300 bp size fragments of 
the Ad5 sequence located between and adjacent to the unique sites ApaI and SwaI in 
pZero2E3.6.9. The sense primer of the 160 bp (upstream) PCR fragment and the anti-sense 
primer of the 300 bp (downstream) PCR fragment contained sequences of ApaI and SwaI, 
respectively. The other PCR primer pairs contained an artificially generated ClaI site. The PCR 
products from the first step reaction were digested with ClaI and ligated together to serve as a 
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template for PCR amplification with the external sense (ApaI) and anti-sense (SwaI) primers 
used in the first step reactions. The 450 bp chimera product was then digested with ApaI and 
SwaI and used to replace ApaI-SwaI restriction fragment in pZero2E3.6.9 thereby deleting E3 
sequence. The resulting E3 deletion (Ad5 nts: 28,133-30,817) contains extra 3 nucleotides at 
each side of the deletion as compared to the one in the commercial AdEasy-1 (deletion of Ad5 
nts: 28,130-30,820). 
Protein electrophoresis and Western blot. Samples of CsCl-purified Ad5Luc1-HFpIIIa, 
Ad5GLFlagIIIa, Ad5H6IIIa, and Ad5GL virions, or lysates of infected cells, were boiled in 
Laemmli loading buffer and subjected to 4-20% gradient SDS-polyacrylamide gel 
electrophoresis (SDS-PAGE) to separate viral proteins. To analyze the N-terminally modified 
IIIa expressed during viral infection in 293 cells, the cell monolayers were inoculated with 
Ad5Luc1-HFpIIIa, Ad5GLFlagIIIa, Ad5H6IIIa, or Ad5GL at a multiplicity of infection (MOI) of 
100 v.p./cell. Uninfected and infected cells were harvested 24 hours post-infection, solubilized at 
1 × 107 cells/mL in lysis buffer (1% NP-40, 20 mM Tris [pH 8.0], 137 mM NaCl, 10% glycerol, 
2 mM EDTA, and 50 µl/mL protease inhibitor cocktail (Sigma, St. Louis, MO)) by gentle 
rocking at 2 - 8° C for 30 minutes, centrifuged at 14,000 × g for 5 minutes, and 20-µl supernatant 
aliquots were used immediately for SDS-PAGE. For Western blot analysis, proteins resolved via 
SDS-PAGE were transferred to PVDF membranes and probed with either anti-Flag M2 mAb 
(Sigma, St. Louis, MO) or Penta-His mAb (Qiagen, Valencia, CA). Bound M2 and Penta-His 
mAb were detected with a secondary goat anti-mouse antibody conjugated to alkaline 
phosphatase (Sigma, St. Louis, MO) by developing the membranes using alkaline phosphatase 
conjugate substrate kit (Bio-Rad Laboratories, Hercules, CA) as recommended by the 
manufacturer. 
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Gene transfer assay. Monolayers of 293 cells grown in a 24-well plate (3 - 5 × 105 cells/well) 
were inoculated with 0.2-ml aliquots of Ad vectors that were incubated at 45°C for different time 
intervals or untreated control virus at MOI of 100 v.p./cell. Ad vectors were allowed to be 
internalized for 30 min and then, infection medium was aspirated, the cells were washed with 
PBS, and incubated in growth medium at 37°C to allow expression of luciferase reporter gene. 
Cells were lysed 20 h postinfection and luciferase activity was analyzed by using the Promega 
(Madison, Wis.) luciferase assay as we previously described 40. 
Immuno-electron microscopy. Samples of Ad5GLflagIIIa and Ad5GL to be used for electron 
microscopy were stored at -70ºC in small aliquots, to avoid repeated freezing and thawing. 
Viruses were adsorbed for 5 min onto glow-discharged, Formvar/carbon coated nickel grids.  
The Ad5GL vector, which is structurally wild type, was used as a negative control. Ad5EZ-pIX-
Flag-10A-6His-F3/3 and Ad5EZ-pIX-Flag-45A-6His-F3/3 vectors with 6-His and FLAG-
containing extensions of different lengths at the C-terminal end of polypeptide IX, were used as 
positive controls. Grids were rinsed in TBS (20 mM Tris-HCl pH 7.8, 150 mM NaCl) for 2 min 
and unspecific binding blocked with TBG (1% cold water fish gelatin, 0.1% bovine serum 
albumin (BSA) in TBS) for 15 min. Grids were then incubated for 50 min with mAb against 
either the 6-His tag (Clontech ref. 631212) or the FLAG peptide (Sigma M2), in dilutions 
ranging from 1:25 to 1:100 in TBS/BSA (100:1).  Grids were rinsed three times with TBG and 
incubated with 15% 10 nm goat anti-mouse IgG-gold conjugate (British Biocell International 
EM.GAF10) in TBS/BSA for 30 min. After three rinses in TBG, and three in TBS, grids were 
stained with 2% uranyl acetate and examined in a JEOL 1200 EX-II electron microscope. For 
gold particle count, micrographs were taken at 25x magnification from areas selected at low 
magnification. 
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Cryo-electron microscopy. Ad5GL and A5GLflagIIIa virus samples were dialyzed for 1 hour at 
4ºC against 10 mM phosphate buffer pH 7.2, 150 mM NaCl, applied to freshly carbon-coated, 
glow discharged Quantifoil R2/4 300 mesh Cu/Rh grids, and vitrified in liquid ethane using a 
Leica CPC plunger. Grids were mounted in a Gatan 626 cryostage and examined in a FEI Tecnai 
G2 FEG microscope operating at 200 kV. Micrographs were recorded on Kodak SO-163 film 
under low dose conditions at a nominal magnification of 50,000x, and digitized in a Zeiss 
Photoscan TD scanner using a step size of 7 µm (1.4 Å in the sample). 
Three-dimensional reconstruction and difference mapping. Image processing and three-
dimensional reconstruction were performed using the software packages Xmipp 42; 43 and 
SPIDER 44. The contrast transfer function (CTF) parameters of each micrograph were 
determined from its rotationally averaged power spectrum, obtained by patch averaging. 
Micrographs free of drift and astigmatism were selected and downsampled to a final pixel size of 
4.2 Å/px. Only those micrographs within a common underfocus range (1.7 to 5 µm) for both 
Ad5GL and Ad5GLflagIIIa were further used for calculation of the 3D maps (66 micrographs for 
Ad5GL, 89 for Ad5GLflagIIIa).  
      Initial sets of 3120 (Ad5GL) and 3870 (Ad5GLflagIIIa) particles were manually selected, 
extracted into 275x275 pixel boxes, and normalized. Images were sorted into defocus groups and 
iterative projection matching was carried out within each group, using as a model the 3D map 
calculated in the previous iteration, affected by the corresponding CTF 45. For every iteration, 
separate 3D reconstructions were calculated in each defocus group and then combined into a 
Wiener filter CTF corrected map 46. The initial model for the first projection matching iteration 
was a previously obtained Ad5 3D map 18. Particles giving the worst correlation coefficient 
values during projection matching were rejected. A total of 2575 (Ad5GL) and 3171 
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(Ad5GLflagIIIa) particles were included in the final 3D reconstructions. The resolution of the 3D 
maps was estimated using the FSC=0.5 criterion, considering only a shell loosely containing the 
icosahedrally ordered part of the capsid (radii 294 to 504 Å). Icosahedral symmetry was imposed 
throughout projection matching and reconstruction. 
Single particle reconstruction (SPR) based classification. A 3D map was calculated from 
every single image in the Ad5GLflagIIIa dataset filtered at 30 Å, using the orientations 
determined by projection matching, and with icosahedral symmetry enforced. We have 
previously shown that the use of the iterative reconstruction algorithm ART 47 with a low-
resolution starting volume considerable reduces artifacts in SPRs, a particularly critical feature 
when the region of interest for classification falls close to the icosahedral symmetry axes 18. 
Therefore, we calculated SPRs with ART using a starting volume created from a dataset 
containing two images from each defocus group (44 images in total), filtered to 30 Å resolution. 
SPR calculations were carried out in an HP Proliant cluster with 32 nodes and 2 Intel Xeon 3.06 
GHz CPUs per node. The average density value of each SPR within a mask covering the penton 
was calculated and used to select two SPR subsets, each containing approximately 1/3rd of the 
complete dataset, with either the strongest or the weakest penton density values. The 
corresponding experimental images were then used to calculate two 3D maps, one with the 
highest penton density images and another one with the lowest (977 and 972 images 
respectively). For the Ad5GL control, 980 experimental images were randomly selected covering 
a defocus range similar to that of the SPR-selected Ad5GLflagIIIa subsets, and a 3D 
reconstruction calculated. Penton occupancy for each map was defined as the penton/hexon 
density ratio, with the value for Ad5GL taken as 100%. The ratios were calculated for all maps 
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by comparing their average density values within masks that segmented either the penton or one 
of the peripentonal hexons. 
Difference maps. To calculate the various difference maps, 3D maps to be compared were 
filtered to a common resolution limit, grayscale normalized within radii 294 to 504 Å, centered, 
and brought to a common scale before subtraction. The difference values were normalized to 
average 0 and standard deviation 1 within the same radii. 
Fitting of high resolution structures. A FLAG peptide structure model was taken from the 
crystal structure of peptidylglycan hydrolase ALE-1 (PDB ID 1R77) and fitted to the 
Ad5GLflagIIIa-Ad5GL difference peak, using UCSF Chimera 48. The structures of penton base 
and the peripentonal hexons from a previously reported Ad5 quasi-atomic model 17 (PDB ID 
2BLD) were obtained from the VIPERDB virus structure database 49. After manually placing the 
models onto the Ad5GL 3D map, the fit was refined using UCSF Chimera. Surfaces for the high 
resolution structures were calculated and displayed with the UCSF Chimera Multiscale Models 
tool. 
3DEM database submission and entry IDs. The Ad5GL and Ad5GLflagIIIa 3DEM maps have 
been deposited at the Macromolecular Structure Database (MSD, http://www.ebi.ac.uk/msd) 
with accession codes EMD-1489 and EMD-1490, respectively. 
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Figure Legends 
Fig 1. Schematic representation of modified IIIa proteins indicating non-native N-terminal 
extensions size and structure. 
 
Fig 2. (A) Detection of 6-His- or FLAG-tagged IIIa proteins expressed by the generated Ad 
variants. Samples of 293 cells infected with Ad5GL (lane 2), Ad5H6IIIa (lane 3), Ad5Luc1-
HFpIIIa (lane 4), or Ad5GLflagIIIa (lane 5) were analyzed by Western blot using anti-6-His 
Penta-His (upper panel) or anti-Flag M2 mAb (lower panel). Molecular masses of marker 
proteins (lane 1) indicated in kilodaltons on the left. (B) Detection of modified protein IIIa in the 
Ad capsid. Samples of defective particles of Ad5GL (lane 2), Ad5H6IIIa (lane 3), Ad5Luc1-
HFpIIIa (lane 4), and Ad5GLflagIIIa (lane 5) or mature Ad5GL (lane 6), Ad5H6IIIa (lane 7), 
Ad5Luc1-HFpIIIa (lane 8), and Ad5GLflagIIIa (lane 9) virions purified by centrifugation on 
CsCl gradient were analyzed by Western blot using anti-6-His Penta-His (upper panel) or anti-
Flag M2 mAb (lower panel). Molecular masses of marker proteins (lane 1) indicated in 
kilodaltons on the left. 
 
Fig. 3. Thermostability of IIIa-modified Ad vectors. Aliquots of Ad5Luc1-HFpIIIa, 
Ad5GLflagIIIa, and Ad5GL vectors were incubated at 45°C for different time intervals and then 
used to infect 293 cells. Results are presented as the percentages of luciferase activity detected in 
the cells infected with a heat-treated viral sample with respect to luciferase activity determined in 
the cells infected with untreated virus (100%). Each bar represents the cumulative mean ± SD of 
triplicate determinations. Some error bars depicting standard deviations are smaller than the 
symbols. 
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Fig 4. Immuno-EM of Ad5GL, Ad5GLflagIIIa, and Ad5EZ-pIX-Flag-45A-6His F5/3 labeled 
with anti-FLAG mAb diluted 1:25. Arrows indicate gold particles in the Ad5GL and 
Ad5GLflagIIIa panels, both practically devoid of label. The bar represents 200 nm. 
 
Fig 5: (A) Central sections of the Ad5GL and Ad5GLflagIIIa 3D maps and their difference, as 
indicated. Highest density is white. Arrows point to the strongest positive difference peak, 
located underneath the penton. White symbols indicate the icosahedral 5-fold (pentagon) and 2-
fold (ovals) symmetry axes. Sections are perpendicular to an icosahedral 2-fold symmetry axis. 
The scale bar represents 100 Å. (B) Fourier shell correlation curves for the Ad5GL and 
Ad5GLflagIIIa reconstructions. Both maps were filtered to the lowest common resolution (14 Å) 
before calculating the difference map. (C) Central sections of the Ad5GLflagIIIa maps 
calculated with those particles with highest (high) or lowest (low) penton density, and their 
difference with the Ad5GL_subset map (high-subset and low-subset). Arrows indicate 
difference peaks at the same position as that in the global difference map (A). 
 
Fig 6: (A) Surface rendering of the Ad5GL 3DEM map contoured at 1σ level (grey) and the 
Ad5GLflagIIIa – Ad5GL difference map contoured at 3σ (red). The view is looking at the 
penton (indicated with a pentagon) from inside the capsid. The bar represents 100 Å. One of the 
60 difference peaks attributed to the polypeptide IIIa N-terminal extension is indicated with a 
black circle. (B) A zoom in the difference peak indicated with the circle in (A), with the atomic 
structure of the FLAG peptide (blue sticks) fitted into the density (red mesh). (C) as in (A), but 
showing a transversal section of the capsid across the penton. The penton base (pb) and two 
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peripentonal hexons (ph) are labeled. (D) and (E) show the crystal structures for penton base 
(yellow) and peripentonal hexons (light blue) represented as surfaces, and fitted into the Ad5GL 
map, with the difference map in red. The views are as in (A) and (C), respectively. A slab of the 
Ad5GL map is shown in transparent grey in (E). 
  
 
1Table 1. ImmunoEM assay quantitation
Number of gold labels per virus particle
Anti-6-His Anti-FLAG
Intact virions Disrupted virions Intact virions Disrupted virions
Ad5GL 0.04 ± 0.20
(N=100)
0.11 ± 0.33
(N=9)
0.00 ± 0.00
(N=100)
0.21 ± 0.49
(N=53)
Ad5GLflagIIIa 0.10 ± 0.30
(N=100)
0.48 ± 0.94
(N=27)
0.02 ± 0.14
(N=100)
0.38 ± 0.77
(N=40)
Ad5EZ-pIX-Flag-45A-
6His-F3/3
6.79 ± 2.30
(N=100)
5.35 ± 1.97
(N=17)
4.92 ± 2.04
(N=100)
3.60 ± 2.51
(N=35)
Ad5EZ-pIX-Flag-10A-
6His F3/3
3.12 ± 1.67
(N=100)
3.64 ± 1.69
(N=14)
4.52 ± 1.93
(N=100)
3.77 ± 2.01
(N=26)
Table
Ad5GLflagIIIa                    31 / yes
Ad5GL                                  - / yes
Ad5H6IIIa                             6 / yes
Ad5Luc1-HFpIIIa               18 / yes     
Ad5Luc1-H45FpIIIa           60 / no
Ad5Luc1-HeGFPFpIIIa   256 / no
Flag peptide
HHHHHH DYKDDDDKM TG SA MQDATDPA…...585 aa
6-His tag
MQDATDPA……585 aaHHHHHHM
Ad5 pIIIa
MMQDATDPA….585 aa
Flexible linker
(GGGGS)3I MQDATDPA……585 aaHHHHHHM DYKDDDDK D
eGFP DYKDDDDKHHHHHHM TG SA MQDATDPA…...585 aa
DYKDDDDK SAHHHHHHM TG 45Å α-helix MQDATDPA…...585 aa
Extension size (aa) / virus rescue
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